Evergreening, a real phenomenon in pharmaceuticals

This piece aims to contest some of the propositions put forth by professor Prabuddha Ganguli in an article published on Intellectual Property Watch on May 20th, 2016. Prof. Ganguli gives a rather positivistic account, from a legal point of view, of the patent system’s functioning, which is not in itself wrong, but is certainly insufficient. […]

[:en]UAEM calls for a people-centered approach to biomedical R&D as it launches a mapping of alternative R&D initiatives.[:pt]Mapeamento de modelos alternativos de P&D: por um novo sistema[:]

[:en] Washington, D.C. — Today, Universities Allied for Essential Medicines (UAEM) is launching Re:Route, a mapping of alternative biomedical research and development (R&D) initiatives. Launched in time for the United Nations High Level Panel on Access to Medicines dialogue in March 2016,www.AltReRoute.com provides a qualitative review of alternative biomedical R&D initiatives around the world. This student-driven […]

Acesso a Medicamentos em Portugal

post da convidada Eva Fernandes, Quinto ano do Mestrado Integrado em Ciências Farmacêuticas da Faculdade de Farmácia da Universidade do Porto Segundo a OMS (Organização Mundial de Saúde), para alcançar o melhor nível de saúde é necessário que exista igualdade no acesso a fármacos que sejam seguros e económicos[1]. De acordo com “Análise comparativa do […]